Social health insurance and drug spending among cancer inpatients in China.
A social health insurance (SHI) program has been established in China to ensure that people can obtain health care economically and equitably. Our analysis indicates that in 2005-06, 66.5 percent of Chinese citizens were non-SHI inpatients. We also found that drug spending for SHI inpatients was significantly higher than that for non-SHI inpatients. After adjusting for other variables, we found that the SHI coverage was also associated positively with higher drug costs. We present evidence to show that drug spending differences are attributable at least in part to differences in insurance courage.
Zhou
Bo
B
Department of Pharmacology, Nanjing Medical University, China.
Yang
Li
L
Sun
Qingmin
Q
Gu
Haijuan
H
Wang
Bin
B
D000368:Aged; D002681:China; D016527:Drug Costs; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D005102:Health Expenditures / Q000706:statistics & numerical data*; D017722:Hospital Charges; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics*; D009369:Neoplasms / Q000188:drug therapy*; D004364:Pharmaceutical Preparations / Q000191:economics*; D012044:Regression Analysis
D004364:Pharmaceutical Preparations